Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project. Correspondence from Pere Ginès AleksanderKrag and colleagues.
The LiverScreen project is funded by European Union’s Horizon2020 programme under grant agreement no. 847989.Pere Ginès & Isabel GrauperaPere Ginès, Isabel Graupera, Núria Fabrellas & Anita ArslanowPere Ginès, Isabel Graupera & Núria FabrellasPere Ginès, Isabel Graupera & Núria Fabrellas
Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, DenmarkInstitute for Clinical Research, University of Southern Denmark Odense, Odense, DenmarkEpidemiology, Statistics, and Prevention Institute, University of Zurich, Zurich, SwitzerlandDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, the NetherlandsFrank LammertFrank LammertDepartment of Hepatology, Hôpital Beaujon, Assistance...
Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padova, Italy
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Use of mobile diagnostics and digital clinical trials in cardiology - Nature MedicineUse of mobile diagnostics and digital clinical trials in cardiology. Comment from Sinje Gehr, Nandha Kumar Balasubramaniam & Christoph Russmann, Health Campus Goettingen, harvardmed. Published as part of our series - Rethinking Evidence in Medicine.
Consulte Mais informação »
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial - Nature MedicineIn a single-arm phase 2 study, enoblituzumab (a humanized, Fc-engineered, B7-H3-targeting antibody) was found to be safe and showed preliminary evidence of potential clinical activity in men with high-risk localized prostate cancer.
Consulte Mais informação »
Medical imaging data science competitions should report dataset demographics and evaluate for bias - Nature MedicineMedical imaging data science competitions should report dataset demographics and evaluate for bias. Correspondence from Paul Yi UMmedschool and colleagues.
Consulte Mais informação »
'You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drugThe Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a blockbuster drug and very big business.
Consulte Mais informação »
Taste of rural medicine makes doctors more likely to return, UW study showsDoctors who had trained as medical students in rural areas were almost twice as likely to set up their practices in a rural location, researchers say.
Consulte Mais informação »